Company intelligence / Profile preview

Therapeutic Solace

Framingham, Massachusetts, United Statespsychologytoday.com ↗

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Solace Therapeutics develops and commercializes non-surgical office-based treatments for common bladder disorders. Their proprietary technology aims to provide alternatives to current drug and surgical therapies with fewer side effects. As of April 2021, their lead product was enrolling patients in a pivotal US clinical trial for female stress urinary incontinence.

Therapeutic areas: Men's HealthUrologyWomen's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Therapeutic Solace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Therapeutic Solace.

Explore the full profile